Cargando…
Effectiveness and quality of life improvement in young adult schizophrenia patients treated with Abilify Maintena
INTRODUCTION: Treating young patients with schizophrenia is a challenge, as these patients have much to gain from controlled pharmacotherapy and even more to lose with a possible relapse. Treating patients with long-acting injectable antipsychotics avoids the issue of non-compliance, the biggest ris...
Autores principales: | Petrić, D., Kašelan, A., Brozan, S., Žuljan Cvitanović, M., Krnić, D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479490/ http://dx.doi.org/10.1192/j.eurpsy.2023.2228 |
Ejemplares similares
-
Real-life assessment of aripiprazole monthly (Abilify Maintena) in schizophrenia: a Canadian naturalistic non-interventional prospective cohort study
por: Mustafa, Sally, et al.
Publicado: (2019) -
Quality of life of patients with schizophrenia
por: Guermazi, A., et al.
Publicado: (2022) -
Quality of life in patients with schizophrenia
por: Hentati, S., et al.
Publicado: (2021) -
Improving quality of life with nutritional supplementation in Schizophrenia: A literature review
por: Hassan, N., et al.
Publicado: (2022) -
Satisfaction of the quality of life in patients with schizophrenia
por: Ouali, R., et al.
Publicado: (2021)